Oncology Institute, Inc. (TOI) Other Non Operating Income (2020 - 2026)

Oncology Institute (TOI) has 7 years of Other Non Operating Income data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Other Non Operating Income rose 764.36% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.0 million (down 450.72% YoY) and the FY2025 annual result came in at -$12.2 million, down 552.58% from the prior year.
• Other Non Operating Income advanced to $5.0 million in Q1 2026, from -$11.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $5.0 million in Q1 2026 to a low of -$11.0 million in Q4 2025.
• A 5-year average of -$719933.3 and a median of -$55000.0 in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 2297.35% — and 2025, when it tumbled 10767.27%.
• Tracing TOI's Other Non Operating Income over 5 years: stood at $318000.0 in 2022, then plunged by 961.01% to -$2.7 million in 2023, then soared by 202.3% to $2.8 million in 2024, then slumped by 493.86% to -$11.0 million in 2025, then jumped by 145.29% to $5.0 million in 2026.
• The last three Other Non Operating Income figures came in at $5.0 million (Q1 2026), -$11.0 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.